Dr. Grace Blest-Hopley tells Psychedelic Spotlight that the compound has anti-inflammatory effects on the brain, and explains how her team will investigate further through psilocybin retreats for veterans.

MindMed Launches DMT Clinical Trial! Joe Rogan must be excited! In this episode, we'll discuss MindMed 's (NASDAQ: MNMD), ( NEO: MMED) announcement and why I'm personally excited about it. As many of you know, of all the classic psychedelics, in many respects DMT, or dimethyltryptamine, is the most mysterious. When it is consumed, experiencers report being blasted off into an entirely new dimension of being or plane of existence, where you interact with autonomous, intelligent and wise beings. Those who have experienced this often claim that they return to our world with a sense of having learned important lessons, that are either too hard to put into words. Now, we have no idea what is happening in a person’s brain while they are on DMT. Is the experience completely physiological, for example has the DMT essentially initiated some sort of dream-like state while you are still conscious? Or is it more mystical than that? Either way, the simplistic wisdom gained from “the spirit molecule”, as it is often called, has reportedly helped countless people beat their addictions, depression, anxiety and more. Many people liken it to essentially “resetting your brain”. Unfortunately, despite so much anecdotal evidence and entire sub cultures verging on the edge of religions dedicated to the substance, surprisingly little hard science has been done on the drug. This is the reason behind my excitement today! MindMed announced initiation of phase 1 clinical trial of intravenous DMT. Links: MINDMED ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIAL OF INTRAVENOUS DMT: https://thepsychedelicinvestor.com/2021/07/28/mindmed-announces-initiation-of-phase-1-clinical-trial-of-intravenous-dmt/ MindMed's DMT Clinical Trial Specifications: https://clinicaltrials.gov/ct2/show/NCT04353024?term=DMT&draw=2&rank=2 Previous DMT Studies: https://www.nature.com/articles/s41598-020-61169-x https://maps.org/research-archive/ayahuasca/Thomas_et_al_CDAR.pdf Enjoy the episode! Follow us on social media! 🙌 Instagram: @thepsychedelicinvestor Facebook: @thepsychedelicinvestor Want to collaborate? Send us an email at: thepsychedelicinvestor@gmail.com Music from: www.bensound.com Video editing: @themyaholy Check out our Benziga discounts https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #DMT #MNMD

Republican Tracy Pennycuick and Democrat Jennifer O’Mara are the latest politicians to take notice of the proven therapeutic use of psilocybin.